Fasoracetam: A Powerful Nootropic with Potential Mood-Enhancing Benefits
Fasoracetam is a synthetic nootropic compound of the racetam family that is believed to have cognitive-enhancing, mood-lifting, and anti-anxiety effects While it is not as well-known as some other racetams, it has gained attention for its potential benefits, particularly for individuals with attention deficit disorders or those experiencing mood-related issues.
Supplement Summary
| Name | Fasoracetam |
|---|---|
| Category | Cognitive Function / Nootropics |
| Main Uses |
|
| Effectiveness | Moderate - While early studies are promising, more research is needed. |
| Common Dosage | 10-40 mg, 1-3 times daily |
| Price Range | $$-$$$ |
| Forms Available | Capsules Powder |
Pros
- ✅ Potential to enhance cognitive function
- ✅ May help alleviate symptoms of anxiety and depression
- ✅ Shows potential in treating ADHD symptoms
Cons / Side Effects
- ❌ Limited human clinical trials
- ❌ Potential side effects such as headaches and digestive discomfort
- ❌ Long-term effects are unknown
What Is Fasoracetam?
Fasoracetam is a synthetic nootropic compound of the racetam family that is believed to have cognitive-enhancing, mood-lifting, and anti-anxiety effects. While it is not as well-known as some other racetams, it has gained attention for its potential benefits, particularly for individuals with attention deficit disorders or those experiencing mood-related issues.
How It Works
Fasoracetam modulates several neurotransmitter systems, including glutamate, acetylcholine, and GABA, the latter of which it upregulates, potentially leading to improved mood and reduced anxiety. It also affects the cholinergic system, which could explain its cognitive enhancement properties.
Who It's Best For
Individuals looking for cognitive enhancement, mood support, and potential relief from symptoms of ADHD.
Who Should Avoid It
People with known hypersensitivity to Fasoracetam or any component of the formulation should avoid this supplement. It should also be avoided by pregnant or breastfeeding women due to insufficient data on its effects.
Dosage & Usage Tips
Fasoracetam is typically taken at doses of 10-40 mg, 1-3 times per day. It can be taken with or without food. It's always wise to start with a lower dose and gradually increase as needed and tolerated.
Buying Advice & Quality Tips
Look for products that provide a Certificate of Analysis (CoA) to ensure the purity and quality of the Fasoracetam. Avoid products with unnecessary additives or fillers.
Price & Value
Given the potential cognitive and mood benefits, Fasoracetam could be viewed as a good value, particularly if it is effective for the individual user. However, it is somewhat more expensive than other racetams.
Final Verdict
While more research is needed, Fasoracetam holds promise as a potent nootropic that could benefit individuals seeking cognitive enhancement or mood support. However, users should be aware of potential side effects and the lack of long-term studies.
Additional Clinical Research
After conducting a thorough search, I identified one study that explicitly focuses on Fasoracetam. Despite extensive efforts, additional studies meeting the specified criteria were not found. Below is the detailed information on the identified study:
Despite extensive searches using various terms related to Fasoracetam, no additional studies meeting the specified criteria were found. This highlights the limited availability of published research specifically focusing on Fasoracetam. Further research is necessary to comprehensively understand its potential benefits and risks.
RESEARCH SUMMARY: Fasoracetam
KEY FINDINGS:
Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment
- Fasoracetam demonstrated significant improvement in ADHD symptoms among adolescents with specific glutamatergic gene network variants.
- The study involved 30 adolescents aged 12-17 years with ADHD, harboring mutations in mGluR network genes.
- Participants underwent a 5-week, open-label, single-blind, placebo-controlled trial with dose escalation up to 400 mg twice daily.
- Significant improvements were observed in Clinical Global Impressions-Improvement (CGI-I) and Severity (CGI-S) scores from baseline to week 5 (P < 0.001).
- Parental Vanderbilt scores showed significant improvement for subjects with mGluR Tier 1 variants (P < 0.035).
- No significant differences in adverse events were noted between the placebo week and active drug weeks.
Source: Elia et al. (2018)
View Research
https://www.nature.com/articles/s41467-017-02244-2
RESEARCH QUALITY ASSESSMENT:
- The study was published in a reputable peer-reviewed journal, Nature Communications.
- The sample size was relatively small (30 participants), which may limit the generalizability of the findings.
- The open-label design could introduce bias, as both participants and researchers were aware of the treatment being administered.
- Further large-scale, double-blind, placebo-controlled studies are needed to confirm these findings and establish the long-term safety and efficacy of Fasoracetam in treating ADHD.